Type of non Hodgkin's lymphoma-Other-Other Posts on Medivizor
Navigation Menu

Type of non Hodgkin’s lymphoma-Other-Other Posts on Medivizor

How effective is non-myeloablative chemotherapy after high-dose methotrexate-based treatment in patients with primary central nervous system lymphoma?

How effective is non-myeloablative chemotherapy after high-dose methotrexate-based treatment in patients with primary central nervous system lymphoma?

Posted by on Jun 1, 2022 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the outcomes of patients with primary central nervous system lymphoma (PCNSL) on high-dose methotrexate (HD-MTX; Otrexup)-based chemotherapy followed by non-myeloablative consolidation therapy. The study showed that HD-MTX-based chemotherapy with non-myeloablative consolidation therapy is an alternative and...

Read More

How safe and effective is biological drug brentuximab vedotin combined with R-CHP chemotherapy for patients with non-Hodgkin lymphoma?

How safe and effective is biological drug brentuximab vedotin combined with R-CHP chemotherapy for patients with non-Hodgkin lymphoma?

Posted by on May 30, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of adding brentuximab vedotin (Adcetris) to R-CHP (rituximab, cyclophosphamide, doxorubicin, and prednisone) chemotherapy for patients with non-Hodgkin lymphoma (NHL). The authors concluded that the treatment was very effective and safe for patients. Some background Chemotherapy...

Read More

Comparing chemotherapy dosing approaches for patients with non-Hodgkin lymphoma before a stem cell transplant

Posted by on Nov 28, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated two different dosing approaches for busulfan (Busilvex) chemotherapy for patients with non-Hodgkin lymphoma (NHL) before an autologous stem cell transplant (SCT). The authors found that personalizing treatment dose for these patients was more effective than conventional weight-based dosing. Some background...

Read More

Looking for patients to test the effectiveness of chemotherapy and rituximab combination in treating non-Hodgkin’s lymphoma

Looking for patients to test the effectiveness of chemotherapy and rituximab combination in treating non-Hodgkin’s lymphoma

Posted by on Aug 21, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This phase 2 clinical trial  will test the effectiveness of EPOCH, a 5-drug combination chemotherapy, with rituximab (Rituxan) in patients with certain types of non-Hodgkin's lymphoma. The primary outcome will be measured by the overall response and time to disease progression. This trial is being conducted in Maryland, in the...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor